Generalized bullous mucocutaneous eruption mimicking Stevens-Johnson syndrome in the setting of immune checkpoint inhibition: A multicenter case series - 10/10/20
Doi : 10.1016/j.jaad.2020.03.029
Gabriel E. Molina, BA a, b, Zizi Yu, BA a, Ruth K. Foreman, MD, PhD a, c, Kerry L. Reynolds, MD a, d, e, Steven T. Chen, MD, MPH, MS-HPEd a, b, d, ⁎ 
a Harvard Medical School, Boston, Massachusetts
b Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts
c Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts
d Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
e Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts
∗Correspondence to: Steven T. Chen, MD, MPH, 50 Staniford St, 2nd Floor, Boston, MA 0211450 Staniford St, 2nd FloorBostonMA02114
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: This study was approved by the Partners Human Research Committee, the Institutional Review Board of Partners HealthCare (#2017P000501). |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 83 - N° 5
P. 1475-1477 - novembre 2020 Retour au numéro
Article précédent
- Risk factors for recurrent and metastatic cutaneous squamous cell carcinoma in immunocompromised patients
- Joanna Dong, Timothy Lee, Garrett T. Desman, Desiree Ratner
- Safety of oral bicalutamide in female pattern hair loss: A retrospective review of 316 patients
- Fathima Ferial Ismail, Nekma Meah, Lara Trindade de Carvalho, Bevin Bhoyrul, Dmitri Wall, Rodney Sinclair
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?